1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,160 | 1,320 | 11:20 | |
| 1,210 | 1,260 | 11:13 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.03. | NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company | 549 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / March 11, 2025 / NanoViricides, Inc. (the "Company")(NYSE American:NNVC), a clinical-stage global leader developing revolutionary broad-spectrum antiviral drugs that... ► Artikel lesen | |
| 04.03. | Measles Outbreak: NV-387 Promises To Be An Effective Drug To Treat Patients; We are Ready To Work With HHS, Says NanoViricides President Dr. Anil Diwan | 470 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / March 4, 2025 / The HHS Department Secretary Robert F. Kennedy Jr. wrote an Opinion piece in the FoxNews entitled "Measles outbreak is call to action for all of us".... ► Artikel lesen | |
| 19.02. | NanoViricides GAAP EPS of -$0.14 | 2 | Seeking Alpha | ||
| 19.02. | NanoViricides, Inc. Has Filed its Quarterly Report | 433 | ACCESS Newswire | Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu SHELTON, CT / ACCESS Newswire / February 19, 2025 / NanoViricides, Inc. (NYSE... ► Artikel lesen | |
| 14.02. | NANOVIRICIDES, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 11.02. | NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape | 585 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum... ► Artikel lesen | |
| 29.01. | NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025 | 617 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / January 29, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the... ► Artikel lesen | |
| NANOVIRICIDES Aktie jetzt für 0€ handeln | |||||
| 27.01. | NanoViricides Engages CRO for Phase II Clinical Trial | 784 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / January 27, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase... ► Artikel lesen | |
| 13.01. | NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025 | 423 | ACCESS Newswire | SHELTON, CT / ACCESSWIRE / January 13, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus... ► Artikel lesen | |
| 08.01. | NanoViricides: Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals | 594 | ACCESS Newswire | SHELTON, CT / ACCESSWIRE / January 8, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), comments on the many viruses that could cause pandemics that are... ► Artikel lesen | |
| 23.12.24 | NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape | 1.778 | ACCESS Newswire | SHELTON, CT / ACCESSWIRE / December 23, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), says that its broad-spectrum antiviral drug candidate NV-387 is the best weapon to fight a potential... ► Artikel lesen | |
| 12.12.24 | NANOVIRICIDES, INC. - 8-K, Current Report | 5 | SEC Filings | ||
| 15.11.24 | NanoViricides, Inc. Has Filed Its Quarterly Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include MPOX/Smallpox, RSV, Influenza, COVID | 526 | ACCESS Newswire | SHELTON, CT / ACCESSWIRE / November 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending September... ► Artikel lesen | |
| 04.11.24 | NanoViricides to Provide Corporate Update at the Spartan Capital Investors Conference 2024, Today at 9:45am | 738 | ACCESS Newswire | SHELTON, CT / ACCESSWIRE / November 4, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that... ► Artikel lesen | |
| 22.10.24 | NanoViricides President Dr. Diwan to Present at the PODD Conference | 380 | ACCESS Newswire | SHELTON, CT / ACCESSWIRE / October 22, 2024 / NanoViricides, Inc. (NYSE Amer.: NNVC ) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that... ► Artikel lesen | |
| 15.10.24 | NanoViricides President Dr. Diwan Interviwed in PODD Podcast; He Explains the Revolutionary Clinical Stage Broad-Spectrum Antiviral NV-387, and the Potential of the Platform to Revolutionize Fields Beyond Virology | 551 | ACCESS Newswire | SHELTON, CT / ACCESSWIRE / October 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that... ► Artikel lesen | |
| 14.10.24 | NanoViricides Inc. (NNVC): Best Nanotech Penny Stock to Buy | 3 | Insider Monkey | ||
| 08.10.24 | InvestorNewsBreaks - NanoViricides Inc. (NYSE American: NNVC) to Discuss Its 'Trojan Horse' Platform Technology at Upcoming Global AMR Summit | 1 | iNVEZZ.com | ||
| 08.10.24 | NanoViricides to Present at the Global AMR Summit 2024 Tomorrow | 523 | ACCESS Newswire | Dr. Diwan to Discuss "Shape-Shifting", "Trojan Horse", Pathogen-Directed Attack Capability of NanoViricides Platform Technology to Combat AMR SHELTON, CT / ACCESSWIRE / October 8, 2024 / NanoViricides... ► Artikel lesen | |
| 30.09.24 | NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include RSV, Influenza, MPOX/Smallpox, COVID | 545 | ACCESS Newswire | SHELTON, CT / ACCESSWIRE / September 30, 2024 / NanoViricides, Inc. (NYSE American:NNVC ) (the "Company"), reports that it has filed its Annual Report on Form 10-K for the fiscal year ending June 30... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
41 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 26,800 | -0,37 % | Hilfe für die Menschheit - was sind die BioTech-Perlen in 2025? BioNTech, Pfizer, Bayer, Formycon, BioNxt, Evotec und Vidac | Ob Infektionen, Herz-Kreislauf-Krankheiten oder Krebs, es gibt 1000 Gründe warum die biotechnologische Forschung für die Menschheit unerlässlich ist. Im Gegensatz zu ihren Anfängen ist sie heute von... ► Artikel lesen | |
| ONTO INNOVATION | 131,00 | 0,00 % | Onto Innovation Reports 2024 Fourth Quarter and Full Year Results | WILMINGTON, Mass.--(BUSINESS WIRE)--Onto Innovation Inc. (NYSE: ONTO) ("Onto Innovation," "Onto," or the "Company") today announced financial results for the fourth quarter and full year 2024.
2024... ► Artikel lesen | |
| GAUZY | 9,400 | 0,00 % | Gauzy Ltd. adds Second Production Shift in Europe to Meet Strong Global Demand; Releases Preliminary Third Quarter Revenue Range and Provides Fourth Quarter Guidance | TEL AVIV, Israel, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control solutions, today announced that it has added a... ► Artikel lesen | |
| KOPIN | 1,168 | -4,81 % | Kopin Aktie: Position am Markt untersucht | Die Technologiefirma zeigt trotz aktueller Kursschwankungen positive Entwicklungen im Umsatz und strategische Fortschritte im Bereich Augmented Reality-Displays. Kopin Corporation verzeichnet aktuell... ► Artikel lesen | |
| FENDX TECHNOLOGIES | 0,073 | +5,17 % | FendX Technologies Inc.: FendX Announces Grant of Stock Options and RSUs | Oakville, Ontario--(Newsfile Corp. - March 21, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a nanotechnology company developing surface protection... ► Artikel lesen | |
| OBDUCAT | 0,040 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025 | Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen | |
| ACACIA RESEARCH | 3,080 | -0,65 % | Acacia Research Reports Third Quarter 2024 Financial Results | NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company"), which acquires and operates businesses across the industrial, energy and technology sectors, today... ► Artikel lesen | |
| NVE | 61,50 | +2,50 % | Dividendenbekanntmachungen (03.02.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUITY BRANDS INC US00508Y1029 0,17 USD 0,1641 EUR AMERISERV FINANCIAL INC US03074A1025 0,03 USD 0,0289 EUR AON PLC IE00BLP1HW54 0... ► Artikel lesen | |
| ADVANCE ZINCTEK | 0,440 | 0,00 % | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | ||
| LEHNER INVESTMENTS | 0,028 | -1,75 % | EQS-News: LEHNER INVESTMENTS AG: Alpay Ece verstärkt den Vorstand | EQS-News: LEHNER INVESTMENTS AG
/ Schlagwort(e): Personalie
LEHNER INVESTMENTS AG: Alpay Ece verstärkt den Vorstand
25.11.2024 / 16:15 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| NANOFOCUS | 0,741 | 0,00 % | NanoFocus schließt Kapitalerhöhung ab | Die NanoFocus AG hat die beschlossene Kapitalerhöhung gegen Sach- und Bareinlagen durchgeführt. Insgesamt wurden 6.021.664 neue Aktien zu je 1,00 Euro ausgegeben. Davon gingen 4.276.884 Aktien an die... ► Artikel lesen | |
| RIBER | 3,030 | -0,33 % | Riber: 2024 business growth in line with guidance | 2024 business growth in line with guidance Revenues up +5% to €41.2mOrder book at end-2024: €21.7m Bezons (France), January 29, 2025 - 8:00 am (CET) - RIBER, a global market leader for MBE equipment... ► Artikel lesen | |
| GOMSPACE | 0,834 | 0,00 % | GOMSPACE GROUP AB: GomSpace has reached an agreement regarding a directed share issue of SEK 196 million | ||
| REGION GROUP | 1,195 | +1,36 % | Dividendenbekanntmachungen (30.01.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AZZ INC US0024741045 0,17 USD 0,1631 EUR BANK OF MONTREAL CA0636711016 1,59 CAD 1,0581 EUR DAIWA CYCLE CO LTD JP3501950004 37... ► Artikel lesen | |
| XTPL | 24,600 | +0,61 % | EQS-News: XTPL S.A.: XTPL posts its highest-ever sales in Q4 2024 with growth prospects for 2025 | Issuer: XTPL S.A.
/ Key word(s): Preliminary Results/Sales Result
XTPL posts its highest-ever sales in Q4 2024 with growth prospects for 2025
22.01.2025 / 09:13 CET/CEST
The... ► Artikel lesen |
NANOVIRICIDES INC gehört der Branche Nanotechnologie an. Mit einer aktuellen Kursveränderung von +0,020 (+1,75 %) liegt der Kurs bei 1,160 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NANOVIRICIDES INC finden Sie auf Wallstreet Online.
